+1,080.3%
FLEX vs MRNA
+878.5%
+201.8%
-58.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | -3.6% | +3.4% | -0.1% |
| 7D | -4.3% | -20.0% | +15.7% | -3.4% |
| 30D | -17.3% | -1.3% | -16.1% | -17.3% |
| 3M | -40.7% | +240.0% | -280.7% | -45.2% |
| 6M | -45.7% | +339.0% | -384.7% | -51.4% |
| YTD | +23.8% | +630.0% | -606.2% | +5.8% |
| 1Y | +24.7% | +769.1% | -744.4% | +4.9% |
| 3Y | +276.3% | +181.2% | +95.1% | +236.5% |
| 5Y | +416.2% | -8.1% | +424.3% | +374.4% |
| All | +1,080.3% | +878.5% | +201.8% | +969.2% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling